Abstract
Invasive candidiasis (IC) has become a growing concern for global public health, with the main species causing IC being classified by the WHO as critical and high priority fungal pathogens. IC frequently occurs in immunocompromised patients, and cases of hematological malignancies are risk factors for the incidence of IC, with antifungal resistance representing a significant challenge in …